Friday 6 November 2026 Export BRKR’s income statement to Excel — free account

Bruker Corporation

BRKR Healthcare Medical Devices

Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.

Revenue: +1.57%
EPS: −75.4%
Free cash flow: +278.7%
Total debt: −14.7%

Quarter to September 2026, against a year earlier

61.10 3.04 +5.24%

Follow BRKR

Alert me

Market cap: $8.9B
P/E: 0.0×
Fwd P/E: −412×
Dividend yield: 0.34%
F-score: 4/9
Altman Z: 2.43
Beneish M: −2.56
Dividend safety: 34/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	2.81	2.62	1.59	2.08
P/FCF ratio Full definition →	36.64	77.21	72.24	105.01
P/Operating CF Full definition →	83.54	(118.42)	77.21	31.12
P/B ratio Full definition →	4.11	3.82	2.23	2.89
Price to Tangible BV Full definition →	0.00	89.33	0.00	272.95
EV/Sales Full definition →	3.26	3.09	2.03	2.54
EV/EBITDA Full definition →	72.26	54.16	25.60	30.23
EV/Operating CF Full definition →	33.55	56.75	50.15	65.04
EV/FCF Full definition →	42.55	91.03	92.45	128.07
Quick Ratio Full definition →	0.58	0.61	0.50	0.66
Current Ratio Full definition →	1.84	1.85	1.55	1.73
Net Debt/EBITDA Full definition →	0.00	(224.64)	22.45	11.68
Debt/Assets Full definition →	29.40%	30.15%	27.26%	29.95%
Debt/Equity Full definition →	0.74	0.76	0.68	0.76
Asset Turnover Full definition →	0.57	0.56	0.57	0.57
Operating CF/Net income Full definition →	(0.96)	1.23	20.34	15.42
Capex/Depreciation Full definition →	(0.40)	(0.50)	(0.42)	(0.39)
Research and Development Expense of Revenue Full definition →	10.53%	11.25%	12.30%	10.19%
Selling, General and Administrative Expense of Revenue Full definition →	25.92%	28.49%	29.40%	25.30%
Intangible Assets out of Total Assets Full definition →	0.51	0.38	0.40	0.39
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	2.07%
Graham Net Nets Full definition →	(0.14)	(0.16)	(0.28)	(0.22)
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(1.56%)	(1.16%)	(0.66%)	(0.32%)
Free Cash Flow Yield Full definition →	2.73%	1.30%	1.38%	0.95%
Revenue per Share Full definition →	5.73	5.51	5.41	6.44
Operating CF per Share Full definition →	0.78	(0.51)	0.47	1.51
Capex per Share Full definition →	(0.14)	(0.19)	(0.16)	(0.15)
Free Cash Flow per Share Full definition →	0.63	(0.70)	0.31	1.37
Cash per Share Full definition →	0.78	1.21	0.88	1.97
Shareholders Equity per Share Full definition →	15.12	15.76	16.21	16.29
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	15.12	15.76	16.21	16.29
Free Cash Flow Full definition →	96.70	(106.20)	47.00	207.20
Working Capital Full definition →	985.00	1,020.30	748.50	933.30
Capital Expenditures Full definition →	(21.50)	(28.80)	(24.20)	(22.60)
Net Current Asset Value Full definition →	(1,365.20)	(1,427.70)	(1,560.10)	(1,555.40)
EV/EBIT Full definition →	0.00	0.00	150.97	127.88
Capex to Sales Full definition →	0.02	0.03	0.03	0.02
Price to Operating Income Full definition →	0.00	0.00	117.97	104.86
Other line items
Average Receivables Full definition →	557.40	534.25	540.25	555.20
Average Payables Full definition →	196.10	221.60	256.85	225.00
Average Inventory Full definition →	1,149.65	1,169.20	1,119.00	1,081.20
Average Assets Full definition →	6,131.60	6,196.35	6,031.90	6,024.05
Average Common Equity Full definition →	2,377.75	2,109.80	2,149.95	2,135.30

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly